Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?David P. Funda, Radek Špíšek|Frontiers in Immunology|2019Cited by 14